Legend Biotech (LEGN) Cash & Equivalents Growth (3y) (2022 - 2025)
Legend Biotech (LEGN) Cash & Equivalents Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 24.73% |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -40.88% |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -28.55% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 21.66% |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -16.07% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn | -8.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -28.55% |
| Sep 30, 2025 | -29.99% |
| Jun 30, 2025 | -11.13% |
| Mar 31, 2025 | -13.77% |
| Dec 31, 2024 | -25.34% |
| Sep 30, 2024 | 10.72% |
| Jun 30, 2024 | -25.58% |
| Mar 31, 2024 | 25.35% |
| Dec 31, 2023 | 41.01% |
| Sep 30, 2023 | 126.09% |
| Jun 30, 2023 | 145.48% |
| Mar 31, 2023 | 99.31% |
| Dec 31, 2022 | 111.26% |
| Sep 30, 2022 | 56.96% |
| Jun 30, 2022 | 21.80% |